<

NANOBIOTIX (EPA:NANO) NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call

Transparency directive : regulatory news

28/05/2024 22:15

source : webdisclosure.com



Other stories

07/09/2024 23:50
07/09/2024 18:59
07/09/2024 20:00
07/09/2024 20:08
07/09/2024 23:47
07/09/2024 04:18
07/09/2024 19:42
08/09/2024 00:20
07/09/2024 22:16
07/09/2024 18:46
08/09/2024 01:15
07/09/2024 21:07
07/09/2024 23:37
07/09/2024 20:59
07/09/2024 19:36
07/09/2024 15:54
07/09/2024 07:26
07/09/2024 21:41
07/09/2024 11:29
07/09/2024 10:00
07/09/2024 14:32
07/09/2024 20:11
07/09/2024 22:23
07/09/2024 17:02
07/09/2024 18:05
07/09/2024 23:01
07/09/2024 21:08
07/09/2024 21:00
07/09/2024 14:02
07/09/2024 22:15
07/09/2024 13:30
07/09/2024 01:25
06/09/2024 10:10
07/09/2024 21:41
07/09/2024 20:15
07/09/2024 17:43
06/09/2024 18:00